Experimental Drug Gives New Hope for Congestive Heart Failure Sufferers

Dr. Jennifer Ashton gives insight into the promising new drug giving millions of heart failure patients fresh hope.
1:22 | 08/31/14

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:

{{nextVideo.title}}

{{nextVideo.description}}

Skip to this video now

Now Playing:

{{currentVideo.title}}

More information on this video
Enhanced full screen
Explore related content
Comments
Related Extras
Related Videos
Video Transcript
Transcript for Experimental Drug Gives New Hope for Congestive Heart Failure Sufferers
We turn now to a potential game changer for some 5 million Americans, who suffer from congestive heart failure. News of an experimental drug so successful, that they stopped the study early finding the drug reduced the risk of death and hospitalizations due to heart failure by 20%. ABC's senior medical contributor Dr. Jennifer Ashton is here. Jen, 20%. That is sizable. What makes this a breakthrough? It's a combination of two drugs, that really target the root cause of the problems that plague patients with heart failure. Which is namely fluid overload. It kind of works like a one two punch against the hormonal domino effect. All over the body as well as the heart muscle function better. This study saves lives and improved quality of life all with acceptable side effects. If this drug is approved, it would be the first new oral medication for heart failure in almost a decade. There are caveats, you want people to know. Absolutely. First of all the study was funded by the maker of the medication. It needs more study in african-american patients who are disproportionately affected by heart failure. Experts are still calling this a break through. But it comes with a hefty price tag it could be as much as $7 a day.

This transcript has been automatically generated and may not be 100% accurate.

{"id":25199173,"title":"Experimental Drug Gives New Hope for Congestive Heart Failure Sufferers","duration":"1:22","description":"Dr. Jennifer Ashton gives insight into the promising new drug giving millions of heart failure patients fresh hope.","section":"WNT","mediaType":"Default"}